Pharmacophore and Virtual Screening of JAK3 inhibitors (original) (raw)

Putative dual inhibitors of Janus kinase 1 and 3 (JAK1/3): Pharmacophore based hierarchical virtual screening

Computational biology and chemistry, 2018

Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening

Bioorganic & Medicinal Chemistry Letters, 2009

3D pharmacophore modeling and docking studies of 1-amino-5H-pyrido [4, 3-b] indol-4-carboxamide inhibitors of Janus Kinase 2(JAK2)

World Journal of Pharmaceutical Sciences

View PDFchevron_right

NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3

Claudio Sandoval

Molecular Cancer, 2010

View PDFchevron_right

Molecular modeling on the identification of potential Janus Kinase 3 (JAK3) inhibitor based on the Indonesian Medicinal Plant Database

Asmiyenti Djaliasrin

Journal of Mathematical and Fundamental Sciences

View PDFchevron_right

In Silico Prediction of Potent Pan-Janus Kinase (JAK3) and CYP3A4 Inhibitors Using 2-Imidazopyridine and 2-Aminopyridone Purinones via Computer-Aided Drug Design

Asmaa Saleh

Research Square (Research Square), 2023

View PDFchevron_right

Design of novel JAK3 Inhibitors towards Rheumatoid Arthritis using molecular docking analysis

Dr Shreshtha sharma

Bioinformation, 2019

View PDFchevron_right

Ligand-based virtual screening for discovery of JAK2 inhibitors

Omar Aljawfi

15th LACCEI International Multi-Conference for Engineering, Education, and Technology, 2017

View PDFchevron_right

Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates

Antonio Lupia

Molecules

View PDFchevron_right

Ligand-based and structure-based approaches in identifying ideal pharmacophore against c-Jun N-terminal kinase-3

Suneel Bommisetty

Journal of Molecular …, 2011

View PDFchevron_right

In silico identification of natural product inhibitors of JAK2

dik ma

Methods (San Diego, Calif.), 2015

View PDFchevron_right

The design of a Janus Kinase 3 (JAK3) specific inhibitor 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) allowing for the interrogation of JAK3 signaling in humans

Mai Shihah binti Haji Abdullah abdullah

Journal of medicinal chemistry, 2017

View PDFchevron_right

Discovery of highly potent, selective, covalent inhibitors of JAK3

Charu Chaudhry

Bioorganic & medicinal chemistry letters, 2017

View PDFchevron_right

Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors

Mai Shihah binti Haji Abdullah abdullah

Journal of Medicinal Chemistry, 2018

View PDFchevron_right

Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol

jonathan george

Journal of Biological Chemistry, 2014

View PDFchevron_right

Development of an enzyme-coupled activity assay for Janus kinase 2 inhibitor screening

Olli Silvennoinen

2023

View PDFchevron_right

Integrated Ligand and Structure based approaches towards developing novel Janus Kinase 2 inhibitors for the treatment of myeloproliferative neoplasms

AMBILI Unni

bioRxiv, 2020

View PDFchevron_right

Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors

Pascal Furet

Bioorganic & Medicinal Chemistry Letters, 2010

View PDFchevron_right

A direct enzyme-linked immunosorbent assay (ELISA) for the quantitative evaluation of Janus Kinase 3 (JAK3) inhibitors

Silke Bauer

Anal. Methods, 2014

View PDFchevron_right

Computer-Aided Drug Design of Novel Derivatives of 2-Amino-7,9-dihydro-8H-purin-8-one as Potent Pan-Janus JAK3 Inhibitors

Asmaa Saleh

Molecules, 2023

View PDFchevron_right

Selective JAK inhibitors

Joy, Yu-Yi Chu

View PDFchevron_right

Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains

Emmanuelle Fantino

Journal of Molecular Biology, 2009

View PDFchevron_right

Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5- d ]pyrrolo[2,3- b ]pyridine Inhibitors

John Tokarski

ACS Medicinal Chemistry Letters, 2015

View PDFchevron_right

Targeting JAK3 Tyrosine Kinase-Linked Signal Transduction Pathways with Rationally-Designed Inhibitors

Ilker Dibirdik

Anti-Cancer Agents in Medicinal Chemistry, 2007

View PDFchevron_right

Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)

Kumar Thakur

Bioorganic & Medicinal Chemistry Letters, 2007

View PDFchevron_right

Pharmacophore and Virtual Screening of JAK3 inhibitors (original) (raw)

Related papers